10.500
+0,96%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +49.5% | -91.6% | 2 / 3 | +4.5% | -4.75 pp | +4.63 pp | +5.2% | 0.64 | 9.92 | 103 | +4,5% | 20,9 | +35,3% | 9.92 | 17.73 | −44,1% |
| Pts | 8 | 0 | 8 | 0 | 0 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 10.500 (close price on 2026-10-19)EPS (TTM): 1.059
Financial charts
1.Revenue & growth
VND bn103Q2/26
1.Revenue & growth
VND bn103Q2/26
2.Profit & growth
VND bn14,0Q2/26
3.Profit mix (Penman)
VND bn72,9Q2/26
4.Margins & cost structure
%33.3%Q2/26
5.Returns & cash cycle
% · days7.2%Q2/26
6.Earnings quality & cash
VND bn82,4Q2/26
7.Asset structure
VND bn1.621Q2/26
8.Funding & debt health
VND bn · times1.621Q2/26
9.Revenue backlog
VND bn59,6Q2/26
10.Valuation
times · %9,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %408Q2/26
Adjusted EPS growth, latest quarter
49.5%
Average adjusted EPS growth, 3 quarters
-91.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26